Company Filing History:
Years Active: 2022
Title: Mi Jeong Kim: Innovator in Guanidine Compounds
Introduction
Mi Jeong Kim is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target mitochondrial functions. Her innovative work focuses on addressing critical health issues, including cancer.
Latest Patents
Mi Jeong Kim holds a patent for guanidine compounds and their use in inhibiting mitochondrial oxidative phosphorylation (OXPHOS). This invention relates to a pharmaceutical composition aimed at preventing or treating OXPHOS-related diseases, especially cancer, by reprogramming cellular metabolism. The patent highlights her commitment to advancing medical treatments through innovative chemical solutions.
Career Highlights
Mi Jeong Kim is currently associated with Immunomet Therapeutics Inc., where she continues to explore groundbreaking research in the field of metabolic diseases. Her work is characterized by a strong focus on the intersection of biochemistry and therapeutic applications.
Collaborations
Some of her notable coworkers include Sung Wuk Kim and Hong Woo Kim, who contribute to her research endeavors and collaborative projects.
Conclusion
Mi Jeong Kim's innovative work in guanidine compounds exemplifies her dedication to advancing medical science. Her contributions are paving the way for new treatments in the fight against cancer and other metabolic diseases.